BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8036749)

  • 1. Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion.
    Flanigan TP; Wisnewski A; Wiest PM; Johnson J; Tzipori S; Hamer D; Lam N; Kresina TF
    Trans Assoc Am Physicians; 1993; 106():86-90. PubMed ID: 8036749
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryptosporidium parvum in patients with chronic diarrhea and AIDS: diagnosis by means of indirect immunofluorescence with monoclonal antibodies].
    Weitz JC; Astorga B
    Rev Med Chil; 1993 Aug; 121(8):923-6. PubMed ID: 8296101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of new monoclonal antibodies against Cryptosporidium parvum sporozoites.
    Camero L; Arrowood M; Shulaw W; Lal AA; Xiao L
    J Eukaryot Microbiol; 1999; 46(5):58S-59S. PubMed ID: 10519248
    [No Abstract]   [Full Text] [Related]  

  • 6. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses.
    Flanigan TP
    Am J Trop Med Hyg; 1994; 50(5 Suppl):29-35. PubMed ID: 8203720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA antibody response to Cryptosporidium parvum is mainly represented by IgA1.
    Favennec L; Comby E; Ballet JJ; Brasseur P
    J Infect Dis; 1995 Jan; 171(1):256. PubMed ID: 7798678
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.
    Elliot BC; Wisnewski AV; Johnson J; Fenwick-Smith D; Wiest P; Hamer D; Kresina T; Flanigan TP
    Infect Immun; 1997 Sep; 65(9):3933-5. PubMed ID: 9284173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro detection of anti-Cryptosporidium parvum antibody secreting cells by polyclonal activation of human tonsil mononuclear cells.
    Comby E; Favennec L; Kapel N; Brasseur P; Gobert JG; Ballet JJ
    J Eukaryot Microbiol; 1994; 41(5):29S-30S. PubMed ID: 7804231
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in scid mice.
    Kobayashi C; Yokoyama H; Nguyen SV; Kodama Y; Kimata T; Izeki M
    Vaccine; 2004 Nov; 23(2):232-5. PubMed ID: 15531042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and cell-mediated immune responses to Cryptosporidium parvum.
    Theodos CM
    Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in cryptosporidiosis: the immune response.
    Riggs MW
    Microbes Infect; 2002 Aug; 4(10):1067-80. PubMed ID: 12191657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.
    White AC; Robinson P; Okhuysen PC; Lewis DE; Shahab I; Lahoti S; DuPont HL; Chappell CL
    J Infect Dis; 2000 Feb; 181(2):701-9. PubMed ID: 10669358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
    Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
    J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
    Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
    Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in immunological research on cryptosporidiosis].
    Chen YT
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(2):138-40. PubMed ID: 8174218
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-reactivities with Cryptosporidium spp. by chicken monoclonal antibodies that recognize avian Eimeria spp.
    Matsubayashi M; Kimata I; Iseki M; Lillehoj HS; Matsuda H; Nakanishi T; Tani H; Sasai K; Baba E
    Vet Parasitol; 2005 Mar; 128(1-2):47-57. PubMed ID: 15725532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-based immunotherapy of cryptosporidiosis.
    Crabb JH
    Adv Parasitol; 1998; 40():121-49. PubMed ID: 9554072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Serologic response to Cryptosporidium in HIV-infected persons: implications for epidemiologic research.
    Eisenberg JN; Priest JW; Lammie PJ; Colford JM
    Emerg Infect Dis; 2001; 7(6):1004-9. PubMed ID: 11747729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.